August 19, 2026

Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development

Imagene AI: Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs August 18, 2026  Imagene AI, a leader in AI-powered precision...

recent articles

Bristol, United Kingdom / Thursday 10th February / GlobeNewswire – Cancer informatics and digital pathology provider Inspirata and the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance (SWAG) announced today a new partnership...

CU Cancer Center member Sachin Wani, MD, is leading a study to test the effectiveness of a novel diagnostic tool to improve detection of early esophageal cancer. On a mission to increase early detection of esophageal cancer, University of...

Combination enhances service offering for hospitals, physicians and patients of both companies NASHVILLE, Tenn.— January 24, 2022 – PathGroup, one of the largest providers of anatomic pathology, digital pathology, clinical, and...

Nijmegen, The Netherlands – LUMO Labs’ pre-seed investment vehicle LUMO Fund II TTT AI announces an investment in Aiosyn B.V. Aiosyn’s clinical diagnostics platform uses AI-powered pathology algorithms to support pathologists with more...

Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations  UPPSALA, Sweden & PHILADELPHIA, PA - February 3, 2022 - Proscia®, the leader in digital and computational...

In honor of World Cancer Day, The Desmoid Tumor Research Foundation is celebrating the success of their virtualized tumor board program enabled through the OncoLens platform Atlanta, GA: In honor of World Cancer Day on February 4th, The...

OR

platinum partners

gold partners

Silver Partners

Media Partners